Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linepharma international limited - mifepriston - tableta - mifepriston 200 mg / 1 tableta - mifepriston

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linepharma international limited - mifepriston - tableta - mifepriston 200 mg / 1 tableta - mifepriston

União Europeia - esloveno - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hidroklorid - multiplo sklerozo, recidivno-nakazila - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 in 5. 1)orpatients s hitro razvijajočimi se hudo recidivno nakazila multiplo sklerozo, opredeljeno z 2 ali več onemogočanje zagonov v enem letu, in z 1 ali več gadolinium krepitev poškodbe na možganih, mri ali znatno povečanje t2 lezije obremenitvi, kot je v primerjavi s predhodnim zadnjih mri.

União Europeia - esloveno - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hidroklorid - multiplo sklerozo, recidivno-nakazila - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 in 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

arrow generics limited - valaciklovir - filmsko obložena tableta - valaciklovir 500 mg / 1 tableta - valaciklovir

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

arrow generics limited - valaciklovir - filmsko obložena tableta - valaciklovir 500 mg / 1 tableta - valaciklovir

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

claris lifesciences limited - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

claris lifesciences limited - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

arrow generics limited - latanoprost - kapljice za oko, raztopina - latanoprost 50 µg / 1 ml - latanoprost

União Europeia - esloveno - EMA (European Medicines Agency)

novartis europharm limited - travoprost - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje zvišanega očesnega tlaka pri odraslih bolnikih z očesno hipertenzijo ali glavkomom odprtega zakotja (glejte poglavje 5. znižanje zvišanega očesnega tlaka pri pediatričnih bolnikih, starih od 2 mesecev do < 18 let, s očesni hipertenzije ali pediatričnih glavkoma (glej poglavje 5.